Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.

Molecular cell | Dec 22, 2000

http://www.ncbi.nlm.nih.gov/pubmed/11163203

Mammalian SWI/SNF complexes utilize either brahma (Brm) or brahma-related gene 1 (Brg1) catalytic subunits to remodel nucleosomes in an ATP-dependent manner. Brm was previously shown to be dispensable, suggesting that Brm and Brg1 are functionally redundant. To test this hypothesis, we have generated a Brg1 null mutation by gene targeting, and, surprisingly, homozygotes die during the periimplantation stage. Furthermore, blastocyst outgrowth studies indicate that neither the inner cell mass nor trophectoderm survives. However, experiments with other cell types demonstrate that Brg1 is not a general cell survival factor. In addition, Brg1 heterozygotes are predisposed to exencephaly and tumors. These results provide evidence that biochemically similar chromatin-remodeling complexes have dramatically different functions during mammalian development.

Pubmed ID: 11163203 RIS Download

Mesh terms: Animals | Blastocyst | Cell Cycle Proteins | Cell Survival | DNA Helicases | DNA-Binding Proteins | Drosophila Proteins | Embryo Loss | Fibroblasts | Gene Deletion | Gene Expression Regulation, Developmental | Genes, Essential | Heterozygote | Histocytochemistry | Homozygote | Mice | Mice, Knockout | Nuclear Proteins | Phenotype | RNA, Messenger | Trans-Activators | Transcription Factors

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, Id: R01 HD036655

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.